Directory Calendar News Careers Alumni Giving

Biostatistics Seminars

Department of Biostatistics Seminar Series


The Department of Biostatistics presents a regular speaker series each semester, generally on Thursday afternoon each week. Diverse experts lecture on their work in biostatistics.

Upcoming Biostats Seminars

Thu 10/25/2018 3:30PM - 4:30PM
Dana L. Tudorascu, University of Pittsburgh
Public Health Auditorium (G23)

Dana Tudorascu, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, will present, “Technical Challenges in the Statistical Analysis of Neuroimaging Studies of Alzheimer's Disease”.
Thu 11/1/2018 3:30PM - 4:30PM
Jingyi (Jessica) Li, University of California, Los Angeles
Public Health Auditorium (G23)

Jingyi (Jessica) Li, Department of Statistics and Department of Human Genetics, University of California, Los Angeles, will present, “Neyman-Pearson Classification Algorithms and NP Receiver Operating Characteristics”.
Thu 11/8/2018 3:30PM - 4:30PM
Hongzhe Lee, University of Pennsylvania
Public Health Auditorium (G23)

Hongzhe Lee, Department of Biostatistics and Epidemiology, University of Pennsylvania, will present, “Optimal Permutation Recovery and Estimation of Bacterial Growth Dynamics”.
Thu 11/29/2018 3:30PM - 4:30PM
Dulal K. Bhaumik, University of Illinois at Chicago
Public Health Auditorium (G23)

Thu 12/6/2018 3:30PM - 4:30PM
Student/Faculty Presentations
Public Health Auditorium (G23)

Previous Biostats Seminars

Biostatistics Seminar Series

Biostatistics Seminar: Wen-Chi Wu, Merck

Thursday 11/9 3:30PM - 5:00PM
Public Health Auditorium (G23)


Biostatistics Seminar guest speaker, Wen-Chi Wu, Merck & Co., Inc., will present, "Challenges and Prospect in the Drug Development – A Statistician’s Perspective."

In pharmaceutical industry, team collaboration works in different functional areas. To be able to convey clear statistical messages to other team members and work efficiently are two key elements on our daily basis. The drug development involves complex multi-stage processes to introduce a new drug to the market. In pre-clinical phase, the process starts from drug formulation development and moves into animal testing to determine the toxicities of the novel compound before conducting clinical trials in human subjects. In this presentation, the first half mainly focuses on the clinical trial development from the design of a protocol to the final reporting based on a statistician’s perspective. The second half will cover case studies including challenges occurred during the trial, practical solutions to overcome the challenges, and potential methods to approach patient-reported outcome questions.

 

Last Updated On Friday, November 03, 2017 by Kapko, Bernadette E
Created On Wednesday, August 09, 2017

Contact

For information on seminars and events in the department, contact:

Bernadette Kapko
bkapko@pitt.edu
412-624-3022

© 2018 by University of Pittsburgh Graduate School of Public Health

Login  |  Sitemap